Medpace Holdings (MEDP) Cash from Financing Activities (2015 - 2026)

Medpace Holdings has reported Cash from Financing Activities for 12 years, with the latest figure at $12.7 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Financing Activities rose 103.66% year-over-year to $12.7 million; the trailing twelve-month figure through Mar 2026 stood at -$501.8 million (up 1.16% YoY), and the FY2025 full-year result was -$860.4 million, down 458.66% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at $12.7 million, down from $22.7 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $22.7 million in Q4 2025, with the low at -$540.6 million in Q2 2025.
• Historically, Cash from Financing Activities has averaged -$115.3 million across 5 years, with a median of -$52.7 million in 2023.
• Annual changes were most pronounced in 2024 — Cash from Financing Activities surged 114.54% — and 2025, when it sank 81265.77%.
• Medpace Holdings' Cash from Financing Activities stood at -$131.1 million in 2022, then soared by 101.16% to $1.5 million in 2023, then slumped by 11170.85% to -$168.6 million in 2024, then jumped by 113.48% to $22.7 million in 2025, then plunged by 44.26% to $12.7 million in 2026.
• The last three Cash from Financing Activities figures came in at $12.7 million (Q1 2026), $22.7 million (Q4 2025), and $3.4 million (Q3 2025), per Business Quant data.